source
- FDA pushes back decision on Capricor’s Duchenne cell therapy, GSK clears hepatitis B drug in JapanThe U.S. Food and Drug Administration has extended its review of Capricor Therapeutics' experimental Duchenne muscular dystrophy cell therapy, deramiocel. The agency moved its decision deadline fro…
- Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood testRoche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.Fierce Biotech · 15h ago↗ source